Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. | ![]() Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | ![]() Microbiotix Microbiotix is a biopharmaceutical company developing small molecule drugs targeting infectious diseases and multi-drug resistant pathogens. | |
Founding Date | Founding Date 2001 | Founding Date 1995 | Founding Date N/A |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Calgary, CA HQ San Francisco, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Worcester, US HQ |
Employees | Employees 19 | Employees 20216% increase | Employees 18 |
Valuation ($) | Valuation ($) 12.9 m | Valuation ($) 737.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $274k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $50k (FY, 2025) | Gross profit $49.5m (FY, 2025) | Gross profit N/A |
Net income | Net income ($7.8m) (FY, 2025) | Net income ($50.3m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 10m | Total funding raised $ 244.7m | Total funding raised N/A |

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company
Microbiotix is a biopharmaceutical company developing small molecule drugs targeting infectious diseases and multi-drug resistant pathogens.
View company